Lack of correlation between serum dopamine-beta-hydroxylase activity and blood pressure in middle-aged men

Area of Science:

• Biochemistry
• Cardiovascular Medicine
• Hypertension Research

Background:

• Serum dopamine-beta-hydroxylase (DBH) is an enzyme involved in catecholamine synthesis.
• Investigating biomarkers for cardiovascular conditions like hypertension is crucial for early diagnosis and prevention.

Purpose of the Study:

• To determine if serum dopamine-beta-hydroxylase (DBH) activity correlates with blood pressure levels in asymptomatic middle-aged men.
• To assess the potential of serum DBH activity as a diagnostic aid for essential hypertension.

Main Methods:

• Serum DBH activity was measured in 1194 asymptomatic middle-aged men.
• Blood pressure (systolic and diastolic) was recorded at baseline.
• Statistical analysis was performed to assess correlations and differences in DBH activity across blood pressure ranges.

Main Results:

• No significant correlation was found between serum DBH activity and systolic or diastolic blood pressure (r = -0.01 and r = +0.02, respectively).
• No significant differences in serum DBH activity were observed across different blood pressure deciles.
• Serum DBH activity was similar in individuals with normal, fluctuating, or fixed hypertensive blood pressure.

Conclusions:

• Serum dopamine-beta-hydroxylase activity does not appear to be a reliable indicator of blood pressure status in middle-aged men.
• The findings suggest that serum DBH activity is not a useful diagnostic aid for essential hypertension in this population.